Bioventus, Inc. (BVS)
8.62
+0.04
(+0.47%)
USD |
NASDAQ |
Feb 23, 11:11
Bioventus Market Cap : 577.34M for Feb. 23, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Abbott Laboratories | 198.37B |
| Accuray, Inc. | 61.29M |
| Alphatec Holdings, Inc. | 1.909B |
| Boston Scientific Corp. | 110.43B |
| Plus Therapeutics, Inc. | 38.41M |
Market Cap Related Metrics
| PE Ratio | 76.83 |
| PS Ratio | 1.027 |
| Price to Book Value | 3.476 |
| Price to Free Cash Flow | 10.83 |
| Price | 8.62 |
| Earnings Yield | 1.30% |
| Operating PE Ratio | 12.07 |
| Normalized PE Ratio | 54.76 |